Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice
暂无分享,去创建一个
M. Gerlinger | C. Braconi | A. Wotherspoon | D. Cunningham | B. Walker | N. Fotiadis | A. Patel | D. Gonzalez de Castro | I. Chau | M. Frampton | N. Valeri | C. Peckitt | A. Gillbanks | D. Watkins | N. Starling | S. Rao | R. Begum | L. S. Teixeira Mendes | S. Moorcraft | L. Yuan | T. Jones | Z. Eltahir | S. Hulkki Wilson | C. Baratelli
[1] Simon Tavaré,et al. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance , 2016, Nature Genetics.
[2] B. Conley. Abstract IA38: NCI MATCH: A national precision medicine trial – Conception, development, and adjustment , 2016 .
[3] Nicolas Servant,et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. , 2015, The Lancet. Oncology.
[4] C. Swanton,et al. The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] Funda Meric-Bernstam,et al. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Lisa M Haley,et al. Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers. , 2015, Archives of pathology & laboratory medicine.
[7] J. Marshall,et al. A pilot study of molecularly tailored therapy for patients with metastatic pancreatic cancer (MPC). , 2015 .
[8] William J. Howat,et al. Tissue fixation and the effect of molecular fixatives on downstream staining procedures , 2014, Methods.
[9] Thomas Bachelot,et al. Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). , 2014, The Lancet. Oncology.
[10] J. Tabernero,et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. , 2013, The New England journal of medicine.
[11] P. Lamy,et al. KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment , 2012, Modern Pathology.
[12] T. Kitajima,et al. The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. , 1993, Pathology, research and practice.